Clinical Trials Logo

Ocular Histoplasmosis clinical trials

View clinical trials related to Ocular Histoplasmosis.

Filter by:
  • None
  • Page 1

NCT ID: NCT01790893 Recruiting - Clinical trials for Ocular Histoplasmosis

Treatment for Presumed Ocular Histoplasmosis

HANDLE
Start date: March 2013
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to monitor safety outcomes for patients being treated with intravitreal aflibercept injections for choroidal neovascularization secondary to Presumed Ocular Histoplasmosis Syndrome.

NCT ID: NCT00272766 Terminated - Clinical trials for Choroidal Neovascularization

Macugen for Histoplasmosis

Start date: February 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety and effect on visual acuity of Macugen (pegaptanib sodium) in patients with subfoveal choroidal neovascularization (CNV) secondary to the ocular histoplasmosis syndrome (OHS).